Individualized High Dose Intravenous Anakinra Treatment in Cancer Patients with COVID-19 Associated Cytokine Storm: A Retrospective Controlled Study.

Published in: Infectious diseases & clinical microbiology (2024)

In the control group, mortality was higher in patients with malignancy compared to those without malignancy, but not in the anakinra group. Also, mortality was higher in patients receiving SoC compared to anakinra. Intravenous high-dose anakinra treatment is safe and effective in patients with COVID-19 accompanying cancer.

Keyphrases

high dose
low dose
papillary thyroid
stem cell transplantation
cardiovascular events
squamous cell
risk factors
type diabetes
squamous cell carcinoma
cardiovascular disease
combination therapy
young adults
childhood cancer
replacement therapy
smoking cessation